5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.17▼ | 2.16▼ | 2.16▼ | 2.25▼ | 2.19▲ |
MA10 | 2.14▼ | 2.16▼ | 2.16▼ | 2.21▲ | 2.03▲ |
MA20 | 2.19▼ | 2.21▼ | 2.19▼ | 2.17▲ | 2.06▲ |
MA50 | 2.15▼ | 2.03▲ | 2.02▲ | 1.98▲ | 2.00▲ |
MA100 | 2.09▲ | 2.10▲ | 2.06▲ | 2.03▲ | 2.23▲ |
MA200 | 2.08▲ | 2.12▼ | 2.07▲ | 1.96▲ | 2.69▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.008▼ | -0.015▼ | -0.012▼ | 0.001▲ | 0.034▲ |
RSI | 46.323▼ | 48.346▼ | 49.457▼ | 59.552▲ | 56.722▲ |
STOCH | 45.252 | 40.604 | 40.604 | 61.853 | 54.125 |
WILL %R | -76.744▼ | -89.247▼ | -89.247▼ | -36.730 | -41.935 |
CCI | -60.042 | -76.617 | -76.617 | 37.828 | 82.667 |
Sunday, August 03, 2025 05:00 PM
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025 Regulatory news: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the ...
|
Monday, July 28, 2025 05:00 PM
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that the company’s CEO Jonathan Dickinson and COO Yannis Morel will participate in ...
|
Friday, March 21, 2025 07:10 AM
Innate Pharma: Moving Into The Padcev Space Mar. 21, 2025 9:10 AM ET Innate Pharma S.A. (IPHA) Stock, IPHYF Stock IPHA, IPHYF 1 Comment 1 Like Galzus Research 2.39K Follower s Play (8min) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/08/25 | 2.27 | 2.27 | 2.19 | 2.24 | 6,325 |
22/08/25 | 2.30 | 2.30 | 2.235 | 2.25 | 4,578 |
21/08/25 | 2.2415 | 2.315 | 2.23 | 2.23 | 4,920 |
20/08/25 | 2.2825 | 2.2833 | 2.22 | 2.23 | 9,067 |
19/08/25 | 2.32 | 2.3314 | 2.26 | 2.31 | 8,129 |
18/08/25 | 2.395 | 2.395 | 2.1755 | 2.235 | 14,257 |
15/08/25 | 2.22 | 2.275 | 2.042 | 2.19 | 7,297 |
14/08/25 | 2.245 | 2.245 | 2.1758 | 2.1758 | 3,797 |
13/08/25 | 2.28 | 2.28 | 2.20 | 2.21 | 7,194 |
12/08/25 | 2.19 | 2.20 | 2.0589 | 2.07 | 4,888 |
|
|
||||
|
|
||||
|
|